A removable implant having a radiation shield adapted to reduce radiation exposure to one or more secondary radio-sensitive tissues during breast cancer radiation therapy is provided herein, the implant including: a radiation-absorbing core adapted to absorb at least a portion of cardiac impact zone radiation when compared to a control, wherein the radiation-absorbing core comprises: a flexible solid polymer; and a plurality of radiation-absorbing members dispersed throughout the flexible solid polymer, wherein the radiation-absorbing core comprises a plurality of zones, each of said zones comprising a distinct capacity for radiation absorption, wherein capacity for radiation absorption is proportional to a sensitivity of the secondary radio-sensitive tissues to radiation, such a zone that shields tissue comparatively more sensitive to radiation comprises a zone having a comparatively higher capacity for radiation absorption, and a zone that shields tissue comparatively less sensitive to radiation comprises a zone having a comparatively lower capacity for radiation absorption. Also provided is an implant having a breast tissue expander disposed on a top face of the flexible casing of the implant. Methods of use of the described implants are also provided herein.

A system for visualizing and modifying the thickness of a compensator for radiation therapy in the context of a desired target and dose coverage thereof includes planar slice image generation module, a visualization unit and an adjustment module. The planar slice image generation module generates a series of planar slice images from a patient image data set disposed with one axis parallel to a radiation beam and one axis perpendicular to the radiation beam. The visualization unit graphically depicts a compensator thickness profile, a target of interest, and/or a dose representation on at least one of the series of planar slice images all in the same plane lying in a beam's longitudinal direction. The adjustment module receives user input of an adjustment of at least one compensator thickness value via a manipulation of the graphical depiction thereof.

A compensating device for use in ion-based radiotherapy may comprise a disk with a number of protrusions may be placed in a radiation beam to affect the ions in the beam in different ways to create an irradiation field from a broad beam. This is particularly useful in FLASH therapy because of the limited time available or modulating the beam. A method of designing such a compensating device is proposed, comprising the steps of obtaining characteristics of an actual treatment plan comprising at least one beam, determining at least one parameter characteristic of the desired energy modulation of the actual plan by performing a dose calculation of the initial plan and, based on the at least one parameter, computing a shape for each of the plurality of elongated elements to modulate the dose of the delivery beam to mimic the dose of the initial plan per beam.

Systems for immobilizing a patient are disclosed. The system includes at least one preform formed from a low melting temperature thermoplastic, the preform being configured to be formed to the anatomy of the patient, at least one frame coupled to the at least one preform, and at least one support configured to support the anatomy of the patient. The system also includes at least one lock mechanism coupled to at least one of the frame and the support and configured to couple the at least one frame to the at least one support, and at least one adjuster mechanism coupled to at least one of the at least one frame and the at least one support and configured to selectively adjust a distance between the at least one frame and the at least one support while the at least one frame is coupled to the at least one support.

Disclosed are a method and an apparatus for manufacturing a radiation intensity bolus. The method comprises the steps of: (a) calculating, by a radiotherapy treatment planning unit, a received 3D radiation dose distribution, planning a bolus to be manufactured, and outputting radiation intensity modulation information; (b) receiving, by a bolus design unit, the radiation intensity modulation information, generating a conversion file for manufacturing bolus, and outputting information about a 3D structure of the bolus to be manufactured; (c) receiving, by a bolus manufacturing unit, the conversion file for manufacturing bolus, verifying a type, location, and size of the bolus to be manufactured, sending the verified data to a 3D printer, and manufacturing the bolus; and (d) obtaining, by an accuracy verification unit, information about a 3D structure of the manufactured bolus and evaluating manufacturing accuracy by comparing the information about the 3D structure of the manufactured bolus with the information about the planned bolus.

An implantable device has a body that is substantially rigid and has a predetermined shape. The body is further bioabsorbable and has a density less than or equal to about 1.03 g/cc. When the device is implanted in a resected cavity in soft tissue, it causes the cavity to conform to the predetermined shape. The implantable device is further imageable due to its density being less than that of soft tissue such that the boundaries of the tissue corresponding to the predetermined shape can be determined.

The invention comprises a method and apparatus for treating a tumor using positively charged particles having passed through an intervening object, comprising the steps of: predetermining an energy reduction of the positively charged particles resultant from the positively charged particles traversing the intervening object along a beam treatment path as a function of relative rotation of the patient and the beam treatment path; generating a radiation treatment plan adjusting energy of the positively charged particles delivered from the synchrotron to the intervening object to yield a desired beam treatment energy of the positively charged particles entering the tumor after compensating for the energy reduction; and optionally detecting a set of the positively charged particles after traversing the intervening object to yield a signal, where the signal is used with knowledge of energy of the positively charged particles exiting the synchrotron to pre-determine the energy reduction along the beam treatment path.

A range shifting device configured to be placed close to a portion of a body of a patient during radiation beam treatment. The radiation beam treatment can include stereotactic radiosurgery (SRS). The range shifting device can be incorporated into an existing SRS localization system during SRS treatment. The range shifting device is configured to be placed close to the head of a patient during SRS treatment. The range shifting device is comprised of range shifting material. The range shifting device can be a range shifting helmet. The range shifting helmet can include a hollow frame including a plurality of apertures in which inserts made of range shifting material can be inserted.

Disclosed is a tumor surface dose enhancing radiotherapy apparatus using a magnetic field, including a radiation beam generating unit that irradiates a radiation beam towards a tumor of a patient, a magnetic field generating unit that forms a magnetic field that is parallel to the radiation beam between the radiation beam generating unit and the tumor of the patient, and a control unit that controls a surface dose of the tumor by adjusting an intensity and an effective area of the magnetic field of the magnetic field generating unit.

A novel treatment method is disclosed, wherein a patch configured to be placed on a patient's skin is activated, before placement, to deliver localized radiotherapy to a diseased area of the skin. The disclosed devices and methods minimize or prevent collateral damage to the neighboring tissues. In most cases, the disclosed devices and methods include coating a contoured, solid, flexible or conformal substrate with one or more lanthanide elements and then activating (e.g. neutron irradiation) the elements such that its resulting radioisotope emits beta-particles into the diseased skin surface when applied to the patient's skin. Novel processes are described for fabricating and irradiating the lanthanide-based skin patch, for example a holmium-based skin patch.